Nuts and Bolts: Microfluidics for the Production of Biomaterials

Research output: Contribution to journalReview ArticleScientificpeer-review

Abstract

Nanotechnology holds the promise of bringing revolutionary therapeutic strategies into the clinic. However, an enormous fraction of the currently proposed nanotechnology‐based therapies suffers from lack of reproducibility, complexity, high costs, and scale‐up‐related issues. For these reasons, the research community is moving toward the miniaturization of biomaterials and fabrication methods. Customizable microfluidic‐based products have gained tremendous relevance in the development of biomedical technologies. This review provides an overview of different materials that can be used for the fabrication of microfluidic devices, as well as the other parameters influencing the production of biomaterials and biosensors. Moreover, several advanced microfluidic‐based technologies that are designed to overcome the current challenges of cancer, immunotherapy, and diabetes therapy, among others are described. Then, the pros and cons of microfluidics as alternative to conventional preparation methods, and the challenges of translating this technique to an industrial context are highlighted. Overall, microfluidic technologies and their accessibility to the research community offer a set of exciting opportunities to bridge the development of innovative therapies and their commercialization in the foreseeable future.
Original languageEnglish
JournalAdvanced Materials Technologies
Volume4
Issue number6
Pages (from-to)21
Number of pages1,800,611
ISSN2365-709X
DOIs
Publication statusPublished - Jun 2019
MoE publication typeA2 Review article in a scientific journal

Cite this

@article{723808bb702941e2af2c0d2591c77716,
title = "Nuts and Bolts: Microfluidics for the Production of Biomaterials",
abstract = "Nanotechnology holds the promise of bringing revolutionary therapeutic strategies into the clinic. However, an enormous fraction of the currently proposed nanotechnology‐based therapies suffers from lack of reproducibility, complexity, high costs, and scale‐up‐related issues. For these reasons, the research community is moving toward the miniaturization of biomaterials and fabrication methods. Customizable microfluidic‐based products have gained tremendous relevance in the development of biomedical technologies. This review provides an overview of different materials that can be used for the fabrication of microfluidic devices, as well as the other parameters influencing the production of biomaterials and biosensors. Moreover, several advanced microfluidic‐based technologies that are designed to overcome the current challenges of cancer, immunotherapy, and diabetes therapy, among others are described. Then, the pros and cons of microfluidics as alternative to conventional preparation methods, and the challenges of translating this technique to an industrial context are highlighted. Overall, microfluidic technologies and their accessibility to the research community offer a set of exciting opportunities to bridge the development of innovative therapies and their commercialization in the foreseeable future.",
author = "Flavia Fontana and {Oliveira Martins}, {Joao Pedro} and Giulia Torrieri and {Almeida Santos}, Helder",
year = "2019",
month = "6",
doi = "10.1002/admt.201800611",
language = "English",
volume = "4",
pages = "21",
journal = "Advanced Materials Technologies",
issn = "2365-709X",
publisher = "John Wiley & Sons Ltd.",
number = "6",

}

Nuts and Bolts: Microfluidics for the Production of Biomaterials. / Fontana, Flavia; Oliveira Martins, Joao Pedro; Torrieri, Giulia; Almeida Santos, Helder.

In: Advanced Materials Technologies, Vol. 4, No. 6, 06.2019, p. 21.

Research output: Contribution to journalReview ArticleScientificpeer-review

TY - JOUR

T1 - Nuts and Bolts: Microfluidics for the Production of Biomaterials

AU - Fontana, Flavia

AU - Oliveira Martins, Joao Pedro

AU - Torrieri, Giulia

AU - Almeida Santos, Helder

PY - 2019/6

Y1 - 2019/6

N2 - Nanotechnology holds the promise of bringing revolutionary therapeutic strategies into the clinic. However, an enormous fraction of the currently proposed nanotechnology‐based therapies suffers from lack of reproducibility, complexity, high costs, and scale‐up‐related issues. For these reasons, the research community is moving toward the miniaturization of biomaterials and fabrication methods. Customizable microfluidic‐based products have gained tremendous relevance in the development of biomedical technologies. This review provides an overview of different materials that can be used for the fabrication of microfluidic devices, as well as the other parameters influencing the production of biomaterials and biosensors. Moreover, several advanced microfluidic‐based technologies that are designed to overcome the current challenges of cancer, immunotherapy, and diabetes therapy, among others are described. Then, the pros and cons of microfluidics as alternative to conventional preparation methods, and the challenges of translating this technique to an industrial context are highlighted. Overall, microfluidic technologies and their accessibility to the research community offer a set of exciting opportunities to bridge the development of innovative therapies and their commercialization in the foreseeable future.

AB - Nanotechnology holds the promise of bringing revolutionary therapeutic strategies into the clinic. However, an enormous fraction of the currently proposed nanotechnology‐based therapies suffers from lack of reproducibility, complexity, high costs, and scale‐up‐related issues. For these reasons, the research community is moving toward the miniaturization of biomaterials and fabrication methods. Customizable microfluidic‐based products have gained tremendous relevance in the development of biomedical technologies. This review provides an overview of different materials that can be used for the fabrication of microfluidic devices, as well as the other parameters influencing the production of biomaterials and biosensors. Moreover, several advanced microfluidic‐based technologies that are designed to overcome the current challenges of cancer, immunotherapy, and diabetes therapy, among others are described. Then, the pros and cons of microfluidics as alternative to conventional preparation methods, and the challenges of translating this technique to an industrial context are highlighted. Overall, microfluidic technologies and their accessibility to the research community offer a set of exciting opportunities to bridge the development of innovative therapies and their commercialization in the foreseeable future.

U2 - 10.1002/admt.201800611

DO - 10.1002/admt.201800611

M3 - Review Article

VL - 4

SP - 21

JO - Advanced Materials Technologies

JF - Advanced Materials Technologies

SN - 2365-709X

IS - 6

ER -